Celgene and Forma enter second collaboration; Celgene gets buy-out option
Celgene Corp. and drug discovery firm Forma Therapeutics Holdings LLC entered into their second partnership in just a year, this time teaming up for the discovery and development of compounds spanning a variety of therapeutic areas including cancer, with the potential for Celgene to buy Forma outright at the end of a possible seven-and-a-half year term.
- Drug Discovery Technologies
- Includes M&A Option
- Intra-Biotech Deal
- R&D and Marketing (Licensing)
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com
All set! This article has been sent to email@example.com.
All fields are required. For multiple recipients, separate email addresses with a semicolon.